Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127105421 | 12710542 | 1 | I | 20160204 | 20160629 | 20160902 | 20160902 | PER | JP-LUPIN PHARMACEUTICALS INC.-2016-03089 | LUPIN | 0.00 | E | M | Y | 0.00000 | 20160902 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127105421 | 12710542 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | Y | UNKNOWN | 78043 | 5 | MG | |||||||
| 127105421 | 12710542 | 2 | C | Cardenaline | 2 | Oral | 0 | 8 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127105421 | 12710542 | 1 | Hypertension |
| 127105421 | 12710542 | 2 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127105421 | 12710542 | Headache | |
| 127105421 | 12710542 | Hot flush | |
| 127105421 | 12710542 | Ocular hyperaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127105421 | 12710542 | 1 | 20160204 | 20160204 | 0 | |
| 127105421 | 12710542 | 2 | 20151117 | 0 |